Gastrointestinal symptoms and gut dysbiosis may occur before the onset of motor symptoms
in Parkinson's disease (PD). Prediagnostic and prodromal features, such as constipation …

The human gastrointestinal tract is home to trillions of microbes. Gut microbial communities
have a significant regulatory role in the intestinal physiology, such as gut motility. Microbial …

The past decade has witnessed an exponential growth of knowledge in the field of gastric
motility. The elucidation of the clinical problems of gastric emptying is based on remarkable …

Synopsis: Since previously reviewed in the Journal (Vol. 12, No. 2), metoclopramide has
been confirmed as an effective drug in treating and preventing various types of vomiting and …

The effects of cisapride (R 51619), a new non-dopamine-blocking gastrokinetic drug, on
gastrointestinal contractility have been determined on isolated preparations of the guinea …

Parkinson's disease (PD) is known to be associated with altered gastrointestinal function
and microbiota composition. To date, the effect of PD medication on the gastrointestinal …

There has been exponential growth in the awareness and understanding of gastrointestinal
(GI) dysfunction in Parkinson's disease (PD) over the past 3 decades. The clinical features of …

Despite widespread use of antivenoms, many questions remain about their effectiveness in
the clinical setting. The almost universal acceptance of their value is based mainly on in vitro …

Parkinson's disease is the second-most common neurodegenerative disorder worldwide.
Besides deciphering the mechanisms that underlie the etiology of the disease, it is important …

The mechanisms by which BRL 24924 ([(+/-)-(endo)])-4-amino-5-chloro-2-methoxy-N-(1-
azabicyclo-[3.3. 1]-non-4-yl) benzamide hydrochloride stimulates gut motility and the …